With Rollout on Amazon, Neonode® Doubles Retail Availability of AirBar™ Sensor
Dec 05, 2016 13:21 pm UTC| Business
STOCKHOLM, Sweden, Dec. 05, 2016 -- Neonode Inc. (NASDAQ:NEON), the Optical Interactive Sensing Technology Company, has announced that it is expanding the AirBar sensor’s market footprint with availability through...
Royal Financial, Inc. Announces Potential Impact of Tax Reform to DTA Value
Dec 05, 2016 13:18 pm UTC| Business
CHICAGO, Dec. 05, 2016 -- Royal Financial, Inc. (the “Company”) (OTCQX:RYFL), the bank holding company for Royal Savings Bank (the “Bank”), has performed an analysis to project the potential impact of hypothetical...
Global Silicone Market will exceed USD 20.0 Billion by 2021, Says Zion Market Research
Dec 05, 2016 13:18 pm UTC| Business
Sarasota, FL, Dec. 05, 2016 -- Zion Research has published a new report titled “Silicone Market (Resins, Elastomers, Gels, Fluids and Others) for Textile, Building Construction, Paper, Chemical Industry, Plastics,...
Dec 05, 2016 13:14 pm UTC| Business
Reinforces CGI’s Position as a Leader in Immuno-Oncology Companion Diagnostics For PD-L1 Testing MonitoringCompany Expects Significant Growth in Comprehensive Molecular Immune Profiling for Lung Cancer as KEYTRUDA...
Avid Announces Major Enhancements to Executive Team to Prepare for Growth Phase
Dec 05, 2016 13:10 pm UTC| Business
Media industry veterans named to key executive roles to strengthen and align customer-facing activities and drive a more customer-centric focus as the company prepares for the end of its transformation and a shift towards...
FXCM US and QuantConnect Announce Live Trading Integration
Dec 05, 2016 13:02 pm UTC| Business
NEW YORK, Dec. 05, 2016 -- Forex Capital Markets LLC, (“FXCM US” or “FXCM" ) the US entity of FXCM Inc. (NASDAQ:FXCM), a global online provider of foreign exchange (FX) trading and related services, announced today Live...
Dec 05, 2016 13:01 pm UTC| Business
HAMPTON, N.J., Dec. 05, 2016 -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) presented data on new product candidate CDX-1140, a fully human antibody targeted to CD40 that has demonstrated potent agonist and anti-lymphoma...